Paper36923950
Artificial intelligence for drug discovery: Resources, methods, and applications.
Chen W and 3 others. Mol Ther Nucleic Acids, 2023. Cited by 135 papers, by iCite.
Cite this record
ConductScience Library. Artificial intelligence for drug discovery: Resources, methods, and applications. Papers, record 36923950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30043127 | Multi-objective de novo drug design with conditional graph generative model. | J Cheminform | 2018 | https://conductscience.org/library/papers/30043127 | PubMed |
| 2 | 33423696 | COCONUT online: Collection of Open Natural Products database. | J Cheminform | 2021 | https://conductscience.org/library/papers/33423696 | PubMed |
| 3 | 25667546 | Large-scale exploration and analysis of drug combinations. | Bioinformatics | 2015 | https://conductscience.org/library/papers/25667546 | PubMed |
| 4 | 36386468 | Emerging biotechnology applications in natural product and synthetic pharmaceutical analyses. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/36386468 | PubMed |
| 5 | 28656625 | The applications of PCA in QSAR studies: A case study on CCR5 antagonists. | Chem Biol Drug Des | 2018 | https://conductscience.org/library/papers/28656625 | PubMed |
| 6 | 30423097 | DeepDTA: deep drug-target binding affinity prediction. | Bioinformatics | 2018 | https://conductscience.org/library/papers/30423097 | PubMed |
| 7 | 33257889 | 'It will change everything': DeepMind's AI makes gigantic leap in solving protein structures. | Nature | 2020 | https://conductscience.org/library/papers/33257889 | PubMed |
| 8 | 35538061 | Artificial intelligence in cancer target identification and drug discovery. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35538061 | PubMed |
| 9 | 34393317 | Machine Learning in Drug Discovery: A Review. | Artif Intell Rev | 2022 | https://conductscience.org/library/papers/34393317 | PubMed |
| 10 | 34339755 | Machine learning predicts 3D printing performance of over 900 drug delivery systems. | J Control Release | 2021 | https://conductscience.org/library/papers/34339755 | PubMed |
| 11 | 18596077 | ChemmineR: a compound mining framework for R. | Bioinformatics | 2008 | https://conductscience.org/library/papers/18596077 | PubMed |
| 12 | 33449558 | Logistic Regression in Medical Research. | Anesth Analg | 2021 | https://conductscience.org/library/papers/33449558 | PubMed |
| 13 | 33151290 | PubChem in 2021: new data content and improved web interfaces. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33151290 | PubMed |
| 14 | 26400459 | The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials. | Nanomedicine (Lond) | 2015 | https://conductscience.org/library/papers/26400459 | PubMed |
| 15 | 29276046 | Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions. | Cell Chem Biol | 2018 | https://conductscience.org/library/papers/29276046 | PubMed |
| 16 | 30976107 | Applications of machine learning in drug discovery and development. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30976107 | PubMed |
| 17 | 28264154 | Deep-Learning-Based Drug-Target Interaction Prediction. | J Proteome Res | 2017 | https://conductscience.org/library/papers/28264154 | PubMed |
| 18 | 31199797 | DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/31199797 | PubMed |
| 19 | 33562347 | Advances in de Novo Drug Design: From Conventional to Machine Learning Methods. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33562347 | PubMed |
| 20 | 33237278 | Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33237278 | PubMed |
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972226 | BENDER DB: a database of protein binding sites across neglected disease proteomes. | BMC Bioinformatics | 2026 | https://conductscience.org/library/papers/42972226 | PubMed |
| 42948771 | HerbWise: A domain-specific large language model for traditional herbal medicine. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/42948771 | PubMed |
| 42934944 | An Integrated Artificial Intelligence Framework for Nanomedicine Engineering. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42934944 | PubMed |
| 42694475 | AI-enabled engineering of hesperidin/ursodeoxycholic acid nanomedicine for synergistic treatment of drug-induced liver injury. | Smart Mol | 2026 | https://conductscience.org/library/papers/42694475 | PubMed |
| 42670843 | Gaps in AI-Driven Pharmacokinetic Property Prediction for Early Drug Development: A Scoping Review. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42670843 | PubMed |
| 42579383 | Reliability of AI Methods in Drug Discovery: Evaluation of Boltz-2 for Structure and Binding Affinity Prediction. | J Chem Theory Comput | 2026 | https://conductscience.org/library/papers/42579383 | PubMed |
| 42565187 | Quantum Reactivity-Guided Optimization of ATP-Competitive Ligands through Multiscale Simulation. | ACS Phys Chem Au | 2026 | https://conductscience.org/library/papers/42565187 | PubMed |
| 42562990 | Deep Learning Pipeline for Accelerating Virtual Screening in Drug Discovery. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42562990 | PubMed |
| 42491104 | Deep learning for small-molecule drug discovery: From molecular design to clinical translation. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42491104 | PubMed |
| 42450132 | Adaptive Self-Attention Graph Pooling for Drug-Target Affinity Prediction. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450132 | PubMed |
| 42446430 | Machine Learning for RNA-Targeting Drug Design. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42446430 | PubMed |
| 42430786 | Advancing bioinformatics with language models: components, applications, and perspectives. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42430786 | PubMed |
| 42353251 | Ensemble Machine Learning- and Deep Learning-Driven Identification and Validation of Sennidin B as a Novel Dipeptidyl Peptidase-4 Inhibitor. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353251 | PubMed |
| 42292068 | The Role of Artificial Intelligence in Modern Analytical Chemistry: Current Trends and Future Directions. | Int J Anal Chem | 2026 | https://conductscience.org/library/papers/42292068 | PubMed |
| 42198370 | From Algorithms to Assets: A Comprehensive Review of AI's Role in Preclinical Drug Discovery and the Hurdles to Clinical Translation. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198370 | PubMed |
| 42180546 | DeepICER: A deep learning framework for predicting compound-induced gene expression profiles. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42180546 | PubMed |
| 42076093 | Functional Peptides: Comparing Synthetic and Sequence-Engineered Antibiofilm Pharmaceutics. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076093 | PubMed |
| 42072712 | In Silico Drug Design and Discovery: Big Data for Small Molecule Design-2nd Edition. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072712 | PubMed |
| 42051590 | AI-driven discovery in protein science for immunology and infectious disease research. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42051590 | PubMed |
| 42005985 | Modernising antiviral drug discovery: harnessing medicinal plants through machine learning and metabolomics to target the SARS-CoV-2 main protease. | In Silico Pharmacol | 2026 | https://conductscience.org/library/papers/42005985 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36923950
GET https://conductscience.org/api/papers/v1/36923950/references?page=2